Risperdal Information
What's inside Risperdal
Risperdal Active Ingredients: risperidone, details.| Risperdal Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Risperdal 0.5 mg | tablet | oral | 1.0 each | OTC |
| Risperdal 3 mg | tablet | oral | 1.0 each | OTC |
| Risperdal 0.25 mg | tablet | oral | 1.0 each | OTC |
| Risperdal 1 mg | tablet | oral | 1.0 each | OTC |
| Risperdal 2 mg | tablet | oral | 1.0 each | OTC |
| Risperdal 4 mg | tablet | oral | 1.0 each | OTC |
| Risperdal 1 mg/mL | solution | oral | 1.0 milliliter(s) | OTC |
Recent Risperdal Side Effects
Posted by broncofan990 12 days ago
I lied about when I was taking risperdal. I took it from the end of 6th grade to before I started 11th grade. When I first st...
Posted by wonderwomyn about 1 month ago
My daughter is a 14 year old mentally disabled child who will be 15 next week. She was prescribed Risperdal last month. Her d...
Posted by bertnik21 2 months ago
I have Bipolar Disorder and was put on risperdal for 3 weeks. 3 weeks only! I had to be taken off of it. It was an amazing dr...
Risperdal in the News
Teva Wants the FDA to Do What? - Motley Fool
In 2001 Teva filed a marketing application for its generic version of Risperdal claiming that J&J's patent was invalid. Later that year, the FDA removed the ...
Wed Mar 05 15:17:40 -0500 2008
Teva files suit against FDA to relist generic risperdal - CNNMoney.com
Risperdal is an antipsychotic medication used to treat schizophrenia and manic states associated with bipolar disorder. The copying, republication or ...
Wed Mar 05 02:38:33 -0500 2008
Teva files suit against FDA to relist generic risperdal - Interactive Investor
Risperdal is an antipsychotic medication used to treat schizophrenia and manic states associated with bipolar disorder. tf.TFN-Europe_newsdesk@thomson.com ...
Wed Mar 05 02:53:18 -0500 2008
Risperdal Chemical Information
risperidone - A benzisoxazole derivative with antipsychotic property. Risperidone selectively antagonizes serotonin (5-HT) effects via cortical 5-HT2 receptor, and, to a lesser extent, competes with dopamine at the limbic dopamine D2 receptor. The antagonism leads to decreased psychotic effects, such as hallucinations and delusions. In addition, risperidone has low to moderate affinity for histamine H1, 5-HT1A, 5-HT1C, and 5-HT1D receptors, while it has weak affinity for dopamine D1 and haloperidol-sensitive sigma site receptors.
Risperdal RSS Feed